Highlights from the
2nd International Workshop on Clinical Pharmacology of HIV Therapy (Athena
TDM) Part 1(Athena
& PharmaAdapt Studies) Part 2 (Triple
PI Drug Therapy; HIV/HCV Co-Infection & Nelfinavir TDM and other Nelfinavir
Reports) Part 3 (Drug
Levels Affect Viral Outcome GART Study; Avoid St. John's Wort with Nevirapine
[Viramune]; Tenofovir DF Levels Increased with Food) Part 4 (Once-Daily
Reports about Saquinavir Plus Ritonavir) Part 5(Other
Saquinavir Reports; NIH Proposes New Drug Interaction Program & Information
Resource; FDA Drafting New Document Targeting HIV Pharmacology) Part 6 ( Absorption
Increased and Variability of Blood Levels Decreased with Food; Blood
Concentrations are Associated with Body Weight; "Inhibitory Quotient"
Correlates with Viral Undetectability Written
by Harvey S. Bartnof, MD, Staff Physician at AVERI, AIDS Virus Education and
Research Institute in San Francisco, California (4/10/2001)
Its Time to Research TDM The Time Has
Come To Accelerate Research Into Using TDM To Adjust Low Drug Blood Levels
For the Purpose Of Improving Viral Load Response to HAART
Written by Jules
Levin (4/5/2001)